LIP
ALDX icon

Lighthouse Investment Partners’s Aldeyra Therapeutics ALDX Stock Holding History

Lighthouse Investment Partners’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,879
Closed -$148K – 283
2023
Q1 		$148K Sell
14,879
-6,994
-32% -$49.4K 0.01% 234
2022
Q4 		$152K Buy
+21,873
New +$125K 0.02% 216

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Lighthouse Investment Partners's ALDX Position: Q2 2023 in Review

Lighthouse Investment Partners sold out of Aldeyra Therapeutics (ALDX) in Q2 2023, closing a stake of 14,879 shares — an estimated $148K sold.

Lighthouse Investment Partners first reported a position in ALDX in Q4 2022 and held it in 2 quarters. The position peaked at $152K in Q4 2022. 119 funds tracked by Wall St. Rank hold ALDX as of Q2 2023.

  • Lighthouse Investment Partners reported no remaining Aldeyra Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Lighthouse Investment Partners sold 14,879 Aldeyra Therapeutics shares in Q2 2023, an estimated $148K.
  • Lighthouse Investment Partners first reported a position in Aldeyra Therapeutics in Q4 2022 and held it in 2 quarters.
  • Lighthouse Investment Partners's Aldeyra Therapeutics position peaked at $152K in Q4 2022.
  • 119 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2023.

Based on Lighthouse Investment Partners's 13F filing for Q2 2023, filed 14 Aug 2023.